How much is Forward Therapeutics worth in 2026?

Forward Therapeutics has a current valuation of N/A based on their Early Stage VC (Series A) round and secondary market data.

How much funding has Forward Therapeutics raised?

Forward Therapeutics has raised N/A in total funding across 1 funding rounds.

Forward Therapeutics

Drug Discovery

Forward Therapeutics valuation and funding history | Last updated: November 3, 2023 | 1 funding rounds

Current Valuation

N/A

As of November 3, 2023

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series A)

$50.0M

Last Funding

Nov 2023

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
November 3, 2023	Early Stage VC (Series A)	$50.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Forward Therapeutics is currently valued at N/A as of November 3, 2023.

Track Forward Therapeutics Valuation Updates

Get notified when Forward Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Forward Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Forward Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Forward Therapeutics Worth in 2026?

Forward Therapeutics is a leading private company in the Drug Discovery sector. Track Forward Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Forward Therapeutics Valuation is Determined

Private company valuations like Forward Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.